Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
OA05 - Clinical Trials in IO
- 13:30 - 15:00
- 9/24/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Advanced NSCLC
-
+
OA05.02 - Epacadostat Plus Pembrolizumab in Patients with Non-Small Cell Lung Cancer: Phase 1/2 Results from ECHO-202/KEYNOTE-037
13:40 - 13:50 | Presenter: Liza Villaruz | Author(s): Bryan J Schneider, Todd M. Bauer, Alexander Spira, Gina D'Amato, Jeffery Wasser, Ani Balmanoukian, Primo Lara, Anthony Olszanski, Thomas Gajewski, Sandip Patel, Ahmad Tarhini, Joshua Michael Bauml, Emmett Schmidt, Jill Bowman, Jeannie Daniel, Sherry Owens, Tara C Mitchell
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-83 - IMpower150: Impact of Chemotherapy Cycles in 1L Metastatic NSCLC in Patients Treated With Atezolizumab + Bevacizumab
16:45 - 18:00 | Presenter: Jeffrey Rothenstein | Author(s): Alexander Spira, Vamsidhar Velcheti, Ronald B Natale, Mark F Kozloff, Michael Kosty, Jerome Goldschmidt Jr., Julien Mazieres, Santiago Ponce Aix, Wei Yu, Mayank Gandhi, Anthony Lee, Geetha Shankar, Wei Lin, Christian A. Thomas
- Abstract
Loading...
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.13-44 - Safety, PK, and Preliminary Antitumor Activity of the Oral EGFR/HER2 Exon 20 Inhibitor TAK-788 in NSCLC
16:45 - 18:00 | Presenter: Joel W. Neal | Author(s): Robert C. Doebele, Gregory J Riely, Alexander Spira, Leora Horn, Zofia Piotrowska, Daniel B Costa, Steven Zhang, Dean Bottino, Jian Zhu, David Kerstein, Shuanglian Li, Pasi A Jänne
- Abstract
Loading...
-
+
P1.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.16-06 - Expanded Efficacy and Safety Analysis of PACIFIC Based on a PD-L1 Cutpoint of 25%
16:45 - 18:00 | Presenter: Alexander Spira | Author(s): David Planchard, Byoung Chul Cho, Mustafa Özgüroğlu, Davey Daniel, Augusto Villegas, David Vicente, Rina Hui, Shuji Murakami, Luis Paz-Ares, Anne-Marie Boothman, Lynne Poole, Catherine Wadsworth, Phillip A. Dennis, Scott J Antonia
- Abstract
Loading...
-
+
PL02 - Presidential Symposium - Top 5 Abstracts
- 08:15 - 09:45
- 9/25/2018
- Location: Plenary Hall
- Type: Plenary Session
- Track: Advanced NSCLC
-
+
PL02.03 - Brigatinib vs Crizotinib in Patients With ALK Inhibitor-Naive Advanced ALK+ NSCLC: First Report of a Phase 3 Trial (ALTA-1L)
08:30 - 08:40 | Presenter: Ross Camidge | Author(s): Hye Ryun Kim, Myung-Ju Ahn, James Chih-Hsin Yang, Ji-Youn Han, Jong-Seok Lee, Maximilian Johannes Hochmair, Jacky Yu-Chung Li, Gee-Chen Chang, Ki Hyeong Lee, Cesare Gridelli, Angelo Delmonte, Maria Rosario Garcia Campelo, Dong-Wan Kim, Alessandra Bearz, Frank Griesinger, Alessandro Morabito, Enriqueta Felip, Raffaele Califano, Sharmistha Ghosh, Alexander Spira, Scott N. Gettinger, Marcello Tiseo, Jeff Haney, David Kerstein, Sanjay Popat
- Abstract
Loading...
-
+
MA21 - Molecular Subtyping, CBL3, and Non Coding RNA
- 15:15 - 16:45
- 9/25/2018
- Location: Room 205 BD
- Type: Mini Oral Abstract Session
- Track: Biology
-
+
MA21.01 - Cbl Mutations (mt) as Important Mediators of Oncogenic RTK Signaling in NSCLC
15:15 - 15:20 | Presenter: Rebecca Feldman | Author(s): Ari M. Vanderwalde, Stephen V Liu, Martin Frederik Dietrich, Shirish Gadgeel, Wolfgang M. Korn, Jorge Nieva, Alexander Spira, Edward S Kim
- Abstract
Loading...